SCHEDULE: Millennium Entities Disclose 5.4% Stake in LivaNova PLC

Millennium Management LLC and affiliated entities have reported a 5.4% beneficial ownership stake in LivaNova PLC as of September 30, 2025.

Summary

• Integrated Core Strategies (US) LLC beneficially owns 2,374,293 Ordinary Shares of LivaNova PLC, representing 4.3% of the class.
• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each beneficially own 2,970,114 Ordinary Shares, representing 5.4% of the class.
• All reporting persons hold shared voting power and shared dispositive power over their respective reported shares.
• The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of LivaNova PLC.
• This filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previous beneficial ownership disclosure.

Sentiment

Score: 5

Explanation: This filing is a routine disclosure of beneficial ownership and does not contain information that would significantly alter the perceived sentiment towards LivaNova PLC. It is a factual update on institutional holdings.

Future Outlook

NA

Industry Context

LivaNova PLC operates in the medical technology industry, focusing on cardiovascular and neuromodulation solutions. The disclosure of a significant institutional stake by Millennium Management LLC and its affiliates indicates continued investor interest in the sector and LivaNova's position within it. Such institutional ownership is common for publicly traded companies in the healthcare and medical device space, reflecting the long-term investment horizons often associated with these industries.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by Millennium Management and its affiliates may be viewed as a vote of confidence by some investors, potentially increasing market visibility and liquidity for LivaNova PLC shares.
• Company Management: Management will be aware of the increased institutional ownership, which could subtly influence strategic communications, although the filing explicitly states no intent to influence control.

Key Dates

Recommendation

This filing is a routine disclosure of beneficial ownership by institutional investors and does not contain new operational or financial information that would fundamentally alter the investment thesis for LivaNova PLC. The reported stakes are significant but do not indicate an activist position or an intent to change company control, suggesting a 'hold' recommendation for existing investors as there is no new catalyst for a 'buy' or 'sell' decision based solely on this filing.

Keywords

LivaNova PLC, Millennium Management LLC, Integrated Core Strategies (US) LLC, Israel A. Englander, Beneficial Ownership, Schedule 13G, Ordinary Shares, Institutional Investor, Medical Devices